Unknown

Dataset Information

0

IL6/STAT3 Signaling Hijacks Estrogen Receptor ? Enhancers to Drive Breast Cancer Metastasis.

ABSTRACT: The cytokine interleukin-6 (IL6) and its downstream effector STAT3 constitute a key oncogenic pathway, which has been thought to be functionally connected to estrogen receptor ? (ER) in breast cancer. We demonstrate that IL6/STAT3 signaling drives metastasis in ER+ breast cancer independent of ER. STAT3 hijacks a subset of ER enhancers to drive a distinct transcriptional program. Although these enhancers are shared by both STAT3 and ER, IL6/STAT3 activity is refractory to standard ER-targeted therapies. Instead, inhibition of STAT3 activity using the JAK inhibitor ruxolitinib decreases breast cancer invasion in vivo. Therefore, IL6/STAT3 and ER oncogenic pathways are functionally decoupled, highlighting the potential of IL6/STAT3-targeted therapies in ER+ breast cancer.

SUBMITTER: Siersbæk R 

PROVIDER: S-EPMC7116707 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The cytokine interleukin-6 (IL6) and its downstream effector STAT3 constitute a key oncogenic pathway, which has been thought to be functionally connected to estrogen receptor α (ER) in breast cancer. We demonstrate that IL6/STAT3 signaling drives metastasis in ER<sup>+</sup> breast cancer independent of ER. STAT3 hijacks a subset of ER enhancers to drive a distinct transcriptional program. Although these enhancers are shared by both STAT3 and ER, IL6/STAT3 activity is refractory to standard ER-  ...[more]

Similar Datasets

Proteomics IL6/STAT3 co-opts ER regulatory elements to drive metastasis in breast cancer
2021-09-08 | PXD012980 | Pride
Proteomics MAF amplification licenses Estrogen Receptor Alpha to drive breast cancer metastasis
2023-11-13 | PXD035936 | Pride
Transcriptomics IL6/STAT3 co-opts ER/FOXA1 regulatory elements to drive metastasis in breast cancer
2020-07-17 | GSE126006 | GEO
Unknown Estrogen receptor α (ERα)-binding super-enhancers drive key mediators that control uterine estrogen responses in mice.
| S-EPMC7307205 | biostudies-literature
Transcriptomics IL6/STAT3 co-opts ER/FOXA1 regulatory elements to drive metastasis in breast cancer (RNA-Seq)
2020-07-17 | GSE126003 | GEO
Genomics IL6/STAT3 co-opts ER/FOXA1 regulatory elements to drive metastasis in breast cancer (ChIP-Seq)
2020-07-17 | GSE126004 | GEO
Genomics IL6/STAT3 co-opts ER/FOXA1 regulatory elements to drive metastasis in breast cancer [ATAC-Seq]
2020-07-17 | GSE150131 | GEO
Genomics MAF Amplification licenses Estrogen Receptor α to Drive Breast Cancer Metastasis
2023-09-15 | GSE210608 | GEO
Transcriptomics MAF Amplification licenses Estrogen Receptor α to Drive Breast Cancer Metastasis.
2023-09-15 | GSE232389 | GEO
Unknown Targeting polarized phenotype of microglia via IL6/JAK2/STAT3 signaling to reduce NSCLC brain metastasis.
| S-EPMC8864012 | biostudies-literature